Table 2.
Correlations of baseline abdominal obesity indices with incident CVD among postmenopausal women after fully adjusted using Model 4
| HR (95% CI) | Indices | ||||
|---|---|---|---|---|---|
| WC | WHR | LAP | VAI | CVAI | |
| Per unit increase | 1.020 (1.000, 1.041)* | 1.009 (0.033, 31.233) | 1.002 (0.999, 1.005) | 1.053 (1.011, 1.096)* | 1.011 (1.004, 1.018)** |
| Per SD increase | 1.210 (1.002, 1.460)* | 1.000 (0.831, 1.204) | 1.097 (0.947, 1.270) | 1.143 (1.029, 1.269)* | 1.407 (1.147, 1.726)** |
| Quartiles | |||||
| Q1 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Q2 | 1.072 (0.596, 1.929) | 0.678 (0.383, 1.201) | 0.804 (0.448, 1.442) | 0.760 (0.443, 1.304) | 0.663 (0.353, 1.244) |
| Q3 | 1.350 (0.771, 2.361) | 0.993 (0.595, 1.656) | 1.053 (0.603, 1.838) | 0.821 (0.478, 1.412) | 0.881 (0.484, 1.605) |
| Q4 | 1.673 (0.973, 2.877) | 1.182 (0.718, 1.944) | 1.747 (1.013, 3.012)* | 1.317 (0.787, 2.203) | 1.893 (1.078, 3.323)* |
Model 4: adjusted by age, education, number of children, smoking, drinking, physical activity, TC, LDL-C, utilization of antihypertensive drugs, antidiabetic drugs and antilipemic drugs, energy intake percentage of fat and carbohydrates, diagnosed with DM and hypertension at baseline and age at menopause
CVD cardiovascular disease, HR hazard ratio, CI confidence interval, WC waist circumference, WHR waist–hip ratio, LAP lipid accumulation product, VAI visceral adiposity index, CVAI Chinese visceral adiposity index, SD standard deviation, TC total cholesterol, LDL-C low-density lipoprotein-cholesterol, DM diabetic mellitus
*p < 0.05
**p < 0.01